Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells
- 31 December 1995
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 31 (3), 389-394
- https://doi.org/10.1016/0959-8049(94)00493-o
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in cultureEuropean Journal Of Cancer, 1994
- Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43°C hyperthermia in sensitive and multidrug-resistant MCF-7 cellsEuropean Journal Of Cancer, 1993
- Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cellsEuropean Journal Of Cancer, 1993
- Effect of liposomes on P-glycoprotein function in multidrug resistant cellsBiochemical and Biophysical Research Communications, 1992
- Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistanceBiochemical Pharmacology, 1992
- P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell linesBritish Journal of Cancer, 1992
- Photoaffinity Labeling of P-Glycoprotein in Multidrug-Resistant CellsCancer Investigation, 1992
- Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivityBlood, 1991